BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 26134004)

  • 1. Transcriptional and Epigenetic Regulation of Oligodendrocyte Development and Myelination in the Central Nervous System.
    Emery B; Lu QR
    Cold Spring Harb Perspect Biol; 2015 Jul; 7(9):a020461. PubMed ID: 26134004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin remodeling and epigenetic regulation of oligodendrocyte myelination and myelin repair.
    Koreman E; Sun X; Lu QR
    Mol Cell Neurosci; 2018 Mar; 87():18-26. PubMed ID: 29254827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin remodelers in oligodendroglia.
    Parras C; Marie C; Zhao C; Lu QR
    Glia; 2020 Aug; 68(8):1604-1618. PubMed ID: 32460418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modifications-insight into oligodendrocyte lineage progression, regeneration, and disease.
    Gregath A; Lu QR
    FEBS Lett; 2018 Apr; 592(7):1063-1078. PubMed ID: 29427507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA Functional Networks in Oligodendrocytes Reveal Stage-Specific Myelination Control by an lncOL1/Suz12 Complex in the CNS.
    He D; Wang J; Lu Y; Deng Y; Zhao C; Xu L; Chen Y; Hu YC; Zhou W; Lu QR
    Neuron; 2017 Jan; 93(2):362-378. PubMed ID: 28041882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of oligodendrocyte differentiation and myelination.
    Emery B
    Science; 2010 Nov; 330(6005):779-82. PubMed ID: 21051629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination.
    Dugas JC; Cuellar TL; Scholze A; Ason B; Ibrahim A; Emery B; Zamanian JL; Foo LC; McManus MT; Barres BA
    Neuron; 2010 Mar; 65(5):597-611. PubMed ID: 20223197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shaping the oligodendrocyte identity by epigenetic control.
    Yu Y; Casaccia P; Lu QR
    Epigenetics; 2010 Feb; 5(2):124-8. PubMed ID: 20160514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Sox4 expression in oligodendrocytes interferes with normal myelination in the central nervous system.
    Potzner MR; Griffel C; Lütjen-Drecoll E; Bösl MR; Wegner M; Sock E
    Mol Cell Biol; 2007 Aug; 27(15):5316-26. PubMed ID: 17515609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of oligodendrocyte differentiation: From development to demyelinating disorders.
    Samudyata ; Castelo-Branco G; Liu J
    Glia; 2020 Aug; 68(8):1619-1630. PubMed ID: 32154951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A zinc finger protein that regulates oligodendrocyte specification, migration and myelination in zebrafish.
    Sidik H; Talbot WS
    Development; 2015 Dec; 142(23):4119-28. PubMed ID: 26459222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination.
    Barateiro A; Fernandes A
    Biochim Biophys Acta; 2014 Sep; 1843(9):1917-29. PubMed ID: 24768715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aligned Brain Extracellular Matrix Promotes Differentiation and Myelination of Human-Induced Pluripotent Stem Cell-Derived Oligodendrocytes.
    Cho AN; Jin Y; Kim S; Kumar S; Shin H; Kang HC; Cho SW
    ACS Appl Mater Interfaces; 2019 May; 11(17):15344-15353. PubMed ID: 30974942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DYT6 Dystonia Protein THAP1 Regulates Myelination within the Oligodendrocyte Lineage.
    Yellajoshyula D; Liang CC; Pappas SS; Penati S; Yang A; Mecano R; Kumaran R; Jou S; Cookson MR; Dauer WT
    Dev Cell; 2017 Jul; 42(1):52-67.e4. PubMed ID: 28697333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox appeal - Sox10 attracts epigenetic and transcriptional regulators in myelinating glia.
    Weider M; Reiprich S; Wegner M
    Biol Chem; 2013 Dec; 394(12):1583-93. PubMed ID: 23729567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrinsic Factors Driving Oligodendrocyte Lineage Cell Progression in CNS Development and Injury.
    Baydyuk M; Morrison VE; Gross PS; Huang JK
    Neurochem Res; 2020 Mar; 45(3):630-642. PubMed ID: 31997102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional and post-transcriptional control of CNS myelination.
    Emery B
    Curr Opin Neurobiol; 2010 Oct; 20(5):601-7. PubMed ID: 20558055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifiers are necessary but not sufficient for reprogramming non-myelinating cells into myelin gene-expressing cells.
    Liu J; Sandoval J; Doh ST; Cai L; López-Rodas G; Casaccia P
    PLoS One; 2010 Sep; 5(9):e13023. PubMed ID: 20885955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms regulating the development of oligodendrocytes and central nervous system myelin.
    Mitew S; Hay CM; Peckham H; Xiao J; Koenning M; Emery B
    Neuroscience; 2014 Sep; 276():29-47. PubMed ID: 24275321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells.
    Nielsen JA; Berndt JA; Hudson LD; Armstrong RC
    Mol Cell Neurosci; 2004 Jan; 25(1):111-23. PubMed ID: 14962745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.